Civic IQ
EQUIPMENTAPPROVED

University of Minnesota Mission Fulfillment Committee Agenda Packet February 2026

University Invests in Ultima UG100 Genome Sequencer

University of Minnesota Board of RegentsULTIMAFebruary 12, 2026

Trusted by teams at

Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo
Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo
Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo
Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo

Description

The University of Minnesota made a major genomics instrumentation investment by purchasing the Ultima UG100 for its Genomics Center, enabling large-scale, cost-effective genome sequencing. The investment positions UMN as a leader in genomics technology with subsidized internal usage rates.

Contract Details

Vendor

ULTIMA

Agency

University of Minnesota Board of Regents, MN

Contract Type

EQUIPMENT

Document Date

February 12, 2026

Contract Term

three-year investment (began 2024)

Renewal Date

2027-12-31

Renewal Info

Three-year investment; continuation contingent on grant and infrastructure program funding.

Bring us your territory.
We'll show you what is forming.

See live SLED buying signals, source docs, decision-makers, contract context, and the next step into your CRM or pipeline.

Try Civic IQ for free